Gianluca Trifirò
Department of Diagnostics and Public Health, University of Verona
Italy
Editor-in-Chief

Promover la seguridad de los pacientes y la transparencia en los procesos regulatorios mediante la publicación global en acceso abierto de evidencia científica rigurosa en el ámbito de la regulación farmacéutica.
About the journal
Start your submission and get more impact for your research by publishing with us.

Ready to publish? Check our author guidelines for everything you need to know about submitting, from choosing a journal and section to preparing your manuscript.

Reviewing a manuscript? See our editor guidelines for everything you need to know about the Frontiers peer review process.

Our rigorous and transparent peer review combines expert assessment with constructive dialogue to strengthen your manuscript.

Article processing charges apply to articles accepted for publication by our external editors after rigorous peer review.
Department of Diagnostics and Public Health, University of Verona
Italy
Editor-in-Chief
University of Florence
Italy
Specialty Chief Editor
Substance-Based Medical Devices
University of Bern
Switzerland
Specialty Chief Editor
Maternal-Fetal Medicine
Netherlands Pharmacovigilance Centre Lareb
Netherlands
Specialty Chief Editor
Vaccine Safety and Regulation
University of Milano-Bicocca
Italy
Specialty Chief Editor
Pharmaceutical Policy and Regulation
University of Pisa
Italy
Specialty Chief Editor
Clinical Drug Safety
Harvard Medical School and Harvard Pilgrim Health Care Institute
United States
Specialty Chief Editor
Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
University of Salerno
Italy
Associate Editor
Substance-Based Medical Devices
99 editors · 0 reviewers
Systematic Review
Published
Alaa Baqer Alali · Fatimah Ahmed Alhammad · Jumanah Ameer Almohammed Saleh · Salwa Baqer Alshaikh · Zahraa Khaled Alshayeb · Anfal Jaber Al Nujaidi · Ahmed Abdulmohsen Albinsaleh · Mohammed Radhi Almutawah · Mostafa Habeeb Alhodibi · Muslem Adel Albesher
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1864872
Systematic Review
Published
Cheewon Ahn · Hyunsuk Jeong · Hyeon Woo Yim · Na Jin Kim · Sungpil Han · Ilhoan Oh
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1855572
Review
Published
Luiz Jupiter Carneiro de Souza · Luis Phillipe Nagem Lopes · Mariana Del Grossi Moura · Katia Miyuki Sasaki Zeredo · José Fernando Salvador Carrillo · Joaquim Lucas Júnior · Mabel Fernandes Figueiró · Jose Antonio Silvestre Fernandes Neto · Luciane Cruz Lopes · Waldecy Rodrigues
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1816967
Review
Published
Hind B. Alshalhoob · Lama M. Albelowi · Aseel S. Alotaibi · Shada Khalid Alanazi · Leen E. Alturki · Zahra Saleh Alsindi · Waad Abdulelah Alduraywish · Sarah Anwar Almulla · Ahmed Anwar Almulla · Nouf Abdulaziz Almagushi · Sarah Khalifah Alkhezzi
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1825005
Original Research
Published
Issei Kazume · Kenji Onda · Sachiko Tanaka · Takashi Yokokawa · Kenichi Suzuki
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1827098
Original Research
Published
Jian-Yu E · Kexin Zhu · Stéphanie Tcherny-Lessenot · Juhaeri Juhaeri
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1792441
Original Research
Published
Omkar Basnet · Rejina Gurung · Pratiksha Bhattarai · Merlind Maria Hofert · Sunil Mani Pokharel · Prajwal Paudel · Ashish K. C.
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1755487
Brief Research Report
Published
Albatol N. Rashed · Ahmed Abdelbasit · Mana Alshahrani
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1767644
Open for submissions
Open for submissions
Open for submissions
El alcance incluye estudios de farmacovigilancia, análisis de datos de reacciones adversas, legislación y regulación de productos biológicos y biosimilares, errores de medicación, farmacoeconomía orientada a la seguridad y políticas de aprobación acelerada o condicional de fármacos.
Promover la seguridad de los pacientes y la transparencia en los procesos regulatorios mediante la publicación global en acceso abierto de evidencia científica rigurosa en el ámbito de la regulación farmacéutica.
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/advanced-methods-in-pharmacovigilance-and-pharmacoepidemiology
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/clinical-drug-safety
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/maternal-fetal-medicine
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/pharmaceutical-policy-and-regulation
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/substance-based-medical-devices
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/vaccine-safety-and-regulation
Fees are charged only after acceptance. Waivers and discounts are available for authors with limited funding.
Fees and waivers policyInternal metrics, calculated on this platform and maintained by the editorial office.
Source: official publisher page · retrieved 2026-10-16
Some values were updated by the editorial office on 2026-10-21.